IL19 and infection: IL-19 level was consistently elevated both during the early phase of SARS-CoV-2 infection (in infected-AECs and COVID-19’s nasopharyngeal swabs) as well as in the acute or hyperinflammatory phase (in COVID-19’s bronchial autopsies) indicating that IL-19 actively participates in the inflammatory response to infection.